Vascular Treatment Articles & Analysis: Older
7 articles found
This precision is crucial in fields like interventional cardiology and vascular treatments. For businesses seeking high-quality marker bands, Edgetech Industries is a trusted marker bands manufacturer, known for delivering customized, durable, and precision-engineered solutions designed to meet specific requirements. ...
Start-up Alucent Biomedical is using a light-activated molecule, delivered via a balloon catheter, to create a natural vascular scaffold in diseased peripheral vessels, with the aim of providing a long-lasting treatment option that maintains patency while leaving nothing behind in the vessel. Alucent Biomedical Inc. is rethinking peripheral artery disease (PAD) ...
Gandhi is an interventional oncologist and a member of the Miami Cardiac & Vascular Institute and Miami Cancer Institute physician team where he specializes in minimally invasive treatments for peripheral vascular disease, cancer, and other diseases, and has a history of being an innovator in the Interventional Robotics ...
IPL The IPL can be used for many different treatments like epidermal pigment removal, acne treatment, spots and freckle removal, and vascular lesions. Treatments with the IPL give the patients a comfortable, cooling sensation. ...
Patient: 48-Year-old male suffering from non-healing surgical wound Medical History: Diabetes, vascular issues, PVD, not a candidate for vascular interventions or HBO treatment Wound History: Patient initially had 2 blisters on great and second toe that lead to great toe amputation. ...
As part of our ongoing Vascular Innovation Series in conjunction with The Way to My Heart, journalist Kym McNicholas interviewed Alucent Biomedical CEO, Dr. Myles Greenberg. Treatment for vascular blockages is getting a much-needed innovation makeover. Alucent’s first area of focus is one the most debilitating vascular ...
This review will investigate the possibility of future design of nano-targeting devices, which home to the endothelial cells of VV or are delivered to the sites of existing plaques and which can deliver specific anti-angiogenic genes or those which will encourage development of mature functional and patent microvessels with a view to prevention and/or treatment of this ...